Status:
RECRUITING
Clinical Characteristics and Outcomes Among STEMI Patients With Cardiogenic Shock at Abu Dhabi City
Lead Sponsor:
Abu Dhabi Health Services Company
Collaborating Sponsors:
Sheikh Shakhbout Medical City
Sheikh Khalifa Medical City
Conditions:
ST Elevation Myocardial Infarction
Cardiogenic Shock
Eligibility:
All Genders
18+ years
Brief Summary
A retrospective study on the clinical characteristics and treatment outcomes of patients admitted with ST-elevation Myocardial Infarction (STEMI) complicated with cardiogenic shock (CS) during admissi...
Detailed Description
Cardiovascular disease (CVD) accounts for 40% of mortality in the UAE, which is higher than the global average. Long-term trends, incidence studies, and best practice guidance on Cardiogenic Shock (CS...
Eligibility Criteria
Inclusion
- Age more than 18.
- STEMI complicated by cardiogenic shock.
- Were hospitalized or treated at SSMC or SKMC for STEMI complicated by cardiogenic shock.
- Patient admitted between January 2019 to March 2024.
Exclusion
- Age less than 18.
- Shock patient not related to Myocardial infarction.
- NSTEMI-related cardiogenic shock.
- Patients who were not treated at SSMC or SKMC for the STEMI complicated by cardiogenic shock.
- Patient not admitted between January 2019 to March 2024.
Key Trial Info
Start Date :
July 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 30 2025
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06535503
Start Date
July 1 2024
End Date
May 30 2025
Last Update
February 17 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Sheikh Khalifa Medical City (SKMC)
Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates, 11001
2
Sheikh Shakhbout Medical City (SKMC)
Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates, 11001